In the present study, we have observed in three independent microarray datasets consisting of 1,105 liver specimens, and an in-house liver cancer patient cohort, that DAPK1 may act as a tumor suppressor gene and its high level expression may be a favorable prognostic marker in liver cancer in both mRNA and protein levels. Here, DAPK1 is linked to liver cancer.